BioStock: Cyxone has gathered new force

Report this content

Biotech company Cyxone has had a busy summer. In June Tara Heitner took over as the new CEO and has since strengthened the team and the internal therapeutic expertise through the recruitment of Christin Arrhenius Bokedal as Head of Development and presented Maarten Kraan and Rikard Holmdahl as the company’s senior scientific advisors. BioStock reached out to the two senior advisors to hear their views on their new positions.

Read the full article about Cyxone at

This is a press release from BioStock - Connecting Innovation & Capital.


Quick facts

BioStock: Cyxone has gathered new force
Tweet this